In patients with advanced HER2-positive gastroesophageal adenocarcinoma, treatment with the bispecific antibody zanidatamab-hrii and chemotherapy, with or without the PD-1 inhibitor tislelizumab-jsgr, reduced the risk of disease progression…
Between new children’s online safety regulations soon entering into force and a handful of recent enforcement actions brought by the U.S. Federal Trade Commission, privacy professionals and other stakeholders are gaining insight into how the…







